FIGO Staging for Gynecologic Cancer
Standardizes staging of gynecologic cancers (cervical, endometrial, ovarian, vulvar, vaginal) to guide treatment and determine prognosis
- Highest activation tier
- Mandatory
- How it is scored
- Scored in code; a stated value is compared only from the structured summary or a supplied value
- Scoring type
- classification
- Care settings
- Inpatient, Outpatient
When it activates
Scribeable activates a calculator from the encounter. The FIGO Staging for Gynecologic Cancer can activate when the transcript or pasted chart context documents any of these:
- Gynecologic cancer staging
- Cervical cancer staging
- Endometrial cancer staging
- Ovarian cancer staging
- Vulvar cancer staging
- Gynecologic malignancy treatment planning
A coded diagnosis can also activate it. ICD-10 prefixes carried by the registry: C51, C52, C53, C54, C56.
Inputs the note needs
1 input. Each is resolved from the transcript, the pasted chart context and charted labs; an input marked "asks you" is requested as a clarification when it is undocumented.
| Input | Type | Unit / options | Guidance |
|---|---|---|---|
| FIGO stage designation (e.g., IA, IB1, IIA, IIB, IIIA, IIIC, IVA, IVB) | exam |
Scoring
Stage I: Confined to organ of origin. Stage II: Extension beyond organ but within pelvis. Stage III: Extension to pelvic sidewall, lower vagina, or regional lymph nodes. Stage IV: Extension to distant organs (IVA: bladder/rectum invasion; IVB: distant metastases). Substages vary by cancer type. Score = major stage number (1-4).
Interpretation
Stage I: Generally favorable prognosis — surgery often curative (cervical IA1: conization; endometrial IA G1-2: hysterectomy). Stage II: Combined modality therapy often needed — surgery + radiation (cervical IIB: chemoradiation). Stage III: Multimodality therapy — neoadjuvant chemotherapy + surgery + radiation for many types. Stage IV: Systemic therapy primary — palliative intent for IVB, multimodal for IVA. 5-year survival varies dramatically: cervical IA >95%, cervical IVB <15%; ovarian IA >90%, ovarian IV <20%. 2018 FIGO update incorporated imaging and pathology findings for cervical cancer staging.
Evidence
Sources carried in Scribeable's citation registry for this calculator; guideline version: FIGO 2018.
- Bhatla N et al. Revised FIGO staging for carcinoma of the cervix uteriFIGO Staging 2018 · 2018 · FIGO · Consensus · link last verified 2026-03-28
How Scribeable handles it in the note
When an encounter activates the FIGO Staging for Gynecologic Cancer at the mandatory tier, Scribeable resolves its inputs from the transcript, the pasted chart context and any charted labs, and asks you for a missing input you can supply before the note is finalised. Bedside-exam and separately ordered study values are not requested one input at a time; a calculator that carries a combined clarification question may still put that single question to you.
The score is computed in code from the resolved inputs, not recalled by the language model. A stated FIGO Staging for Gynecologic Cancer value is compared against the computed one when the draft's structured summary carries it; a disagreement found there is flagged to the second drafting pass, which is instructed to correct the score and its interpretation, unless Scribeable has supplied the computed value to that pass, in which case the value the draft writes is checked against the supplied one and a detected difference is shown beside the note for you to adjudicate rather than silently rewritten.
Classified as a staging or classification system: activated strictly, because a wrong stage on the wrong patient is a documentation hazard.
See it activate on your own encounter
14 days of full Pro. No sales call.
14-day Pro trial, no credit card required. Everything in Pro, including Rounding, for up to 150 notes. To keep Pro after day 14, subscribe for $79/month plus applicable tax. If you don't, nothing is charged and your account becomes read-only, with every note kept.